Antibody Discovery from a Chicken Polyclonal Mixture
Our client is a biotechnology company developing therapeutics that target cancer-specific carbohydrate antigens on the surface of tumour cells.
July 2023
February 2023
Therapeutic Antibody Discovery: From Target to Candidate
Written by: Genya Gorshtein, MSc Published: February 17, 2023 Contents Introduction Target Discovery and Validation Antibody Discovery Characterization and Lead Selection Engineering and Optimization Candidate Selection Therapeutic Antibody Discovery with Rapid Novor Introduction Monoclonal antibodies (mAbs) offer a vast range of configurations for therapeutic applications, [...]
Nanobody Lead Optimization with Epitope Mapping and Binning
In this webinar, you will learn: How Rapid Novor’s de novo polyclonal sequencing platform REpAb® can accelerate any nanobody development pipeline How SPR and HDX-MS integrate into an antibody discovery and development workflow How to choose optimal lead candidates with SPR and HDX-MS How epitopes can be characterized using SPR and HDX-MS [...]
September 2022
Antibody-Drug Conjugates as Anti-Cancer Therapeutics
Written by: Genya Gorshtein, MSc Published: September 14, 2022 Contents Introduction ADCs as Novel Anti-Cancer Chemotherapeutics Key Components of ADCs Future Generation of ADCs De Novo Protein Sequencing Applications in ADC Development Introduction An antibody-drug conjugate (ADC) is a monoclonal antibody (mAb) with a covalently attached [...]